Literature DB >> 6360040

Radiometric macrophage culture assay for rapid evaluation of antileprosy activity of rifampin.

A Mittal, P S Seshadri, H K Prasad, M Sathish, I Nath.   

Abstract

The antileprosy effect of rifampin was evaluated by a newly developed rapid in vitro assay wherein 31 human-derived strains and 1 armadillo-derived strain of Mycobacterium leprae were maintained for 2 and 3 weeks, respectively, in murine and human macrophages in the presence of [3H]thymidine. Of these strains, 27 showed significant incorporation of the radiolabel in cultures of live bacilli as compared with control cultures of heat-killed bacilli of the same strain. Consistent and significant inhibition of [3H]thymidine uptake was observed in M. leprae resident cultures with 3 to 200 ng of rifampin per ml as compared with similar cultures without the drug. In general, an increase in percent inhibition was seen from 3 to 20 ng/ml, with marginal increases at 40, 50, and 100 ng/ml. M. leprae strains appear to be remarkably susceptible to this drug in the in vitro assay.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6360040      PMCID: PMC185377          DOI: 10.1128/AAC.24.4.579

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  The rate of bactericidal action of rifampin on Mycobacterium leprae in the mouse footpad.

Authors:  I B Holmes; G R Hilson
Journal:  Proc Soc Exp Biol Med       Date:  1974-04

2.  The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.

Authors:  I B Holmes; G R Hilson
Journal:  J Med Microbiol       Date:  1972-05       Impact factor: 2.472

3.  Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid.

Authors:  G Boman
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 4.  The use of combinations of antimicrobial drugs.

Authors:  E Jawetz
Journal:  Annu Rev Pharmacol       Date:  1968       Impact factor: 13.820

5.  A method for counting acid-fast bacteria.

Authors:  C C Shepard; D H McRae
Journal:  Int J Lepr Other Mycobact Dis       Date:  1968 Jan-Mar

6.  Kinetic studies on rifampicin. I. Serum concentration analysis in subjects treated with different oral doses over a period of two weeks.

Authors:  G Acocella; V Pagani; M Marchetti; G C Baroni; F B Nicolis
Journal:  Chemotherapy       Date:  1971       Impact factor: 2.544

7.  The activity of various antituberculous drugs in suppressing experimental Mycobacterium leprae infection in mice.

Authors:  G R Hilson; D K Banerjee; I B Holmes
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Apr-Jun

8.  Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.

Authors:  S Furesz; R Scotti; R Pallanza; E Mapelli
Journal:  Arzneimittelforschung       Date:  1967-05

9.  Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae.

Authors:  R J Rees
Journal:  Nature       Date:  1966-08-06       Impact factor: 49.962

10.  Rifampin: antibacterial activity in vitro and absorption and excretion in normal young men.

Authors:  P E Dans; R F McGehee; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1970-02       Impact factor: 2.378

View more
  1 in total

1.  In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.

Authors:  N Ramasesh; J L Krahenbuhl; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.